
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy
Pushpakom, Sudeep, Kolamunnage-Dona, Ruwanthi, Taylor, Claire, Foster, Terry, Spowart, Cath, García-Fiñana, Marta, Kemp, Graham J, Jaki, Thomas, Khoo, Saye, Williamson, Paula, Pirmohamed, Munir, AinswLangue:
english
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/ciz589
Date:
July, 2019
Fichier:
PDF, 1.04 MB
english, 2019